Suchergebnisse - "Belger, Mark"

PubPharm (135)

1

Tirzepatide 10 and 15 mg vs semaglutide 2.0 mg : A long-term cost-effectiveness analysis in patients with type 2 diabetes in the United States

enthalten in: Journal of managed care & specialty pharmacy | 2024

von Mody, R. | Valentine, W. | Hoog, M. | +2

2

Generalizability of clinical trial efficacy results to a real-world population : An example in migraine prevention

enthalten in: Journal of managed care & specialty pharmacy | 2023

von Paget, M. | Tockhorn-Heidenreich, A. | Belger, M. | +2

3

Testing the "RCT augmentation" methodology : A trial simulation study to guide the broadening of trials eligibility criteria and inform on effectiveness

enthalten in: Contemporary clinical trials communications | 2023

von Nordon, C. | Sanchez, B. | Zhang, M. | +5

4

Cost-effectiveness models for Alzheimer's disease and related dementias : IPECAD modeling workshop cross-comparison challenge

enthalten in: Alzheimer's & dementia : the journal of the Alzheimer's Association | 2023

von Handels, R. | Green, C. | Gustavsson, A. | +20

5

Long-term cost-effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States

enthalten in: Diabetes, obesity & metabolism | 2023

von Valentine, W. | Hoog, M. | Mody, R. | +2

6

Sintilimab plus chemotherapy for first-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer : network meta-analysis

enthalten in: Immunotherapy | 2023

von Molife, C. | Brnabic, A. | Stefaniak, V. | +5

7

Validating the Assumptions of Population Adjustment : Application of Multilevel Network Meta-regression to a Network of Treatments for Plaque Psoriasis

enthalten in: Medical decision making : an international journal of the Society for Medical Decision Making | 2023

von Phillippo, D. | Dias, S. | Ades, A. | +5

8

Cost‐effectiveness models for Alzheimer's disease and related dementias : IPECAD modeling workshop cross‐comparison challenge

enthalten in: Alzheimer's & Dementia | 2023

von Handels, R. | Green, C. | Gustavsson, A. | +19

9

Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease

enthalten in: Clinical therapeutics | 2022

von Boustani, M. | Doty, E. | Garrison, L. | +7

10

Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States

enthalten in: Advances in therapy | 2022

von Choong, C. | Belger, M. | Koch, A. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]